| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: present invention refers to pharmaceutics and concerns a liposomal composition containing eribuline or its pharmaceutically acceptable salt, as well as a method for preparing it.EFFECT: invention provides high stability of the liposomal composition.39 cl, 3 dwg, 7 tbl, 10 ex |
